Healthcare, technology, energy, consumer goods, and more. Every day Motley Fool analysts break down a specific industry and the stocks making headlines. Questions? Comments? Email us at IndustryFocus@fool.com.
Most investors will never come in contact with the products that are made by medical device companies. That fact can make it hard for them to research these types of businesses. However, when a medical device company creates a game-changing product it can often go on to create huge shareholder value in time. On this week's episode of Industry Focus: Healthcare, host Shannon Jones sits down with Fool.com's Brian Feroldi to talk about three hidden medical device makers that could be on the verge of generating meaningful returns for their investors: ViewRay,Nervo, and LeMaitre Vascular.
America’s malls are changing. Some well-known retail brands have gone away replaced by digital retailers. That has forced mall operators to be creative in finding alternative ways to fill space. That’s a work in progress at many malls but it’s something the owners of at least some malls have proven successful at doing.
Thanks to Sprout Social for supporting Motley Fool. To learn how your brand can create real connection, visit sproutsocial.com/fool today.
On this week’s episode of Industry Focus: Financials host Jason Moser sits down with Brendan Mathews, VP of Motley Fool Ventures to talk about working in venture capital, the types of companies they're looking at, the differences between public and private investing and some of the big trends the team is following!
Another tech unicorn is going public -- Slack! We break down how the SaaS communication company works, its financials and its $17B valuation. We also explain the company's curious name, and why it has an eerie resemblance to Fool favorite Shopify.
It’s been a wild couple weeks for Fiat Chrysler and Renault. After Fiat made a merger offer in late May, Renault shareholders Nissan and the French government balked at the deal, leading Fiat to withdraw its offer. Motley Fool Senior Auto Analyst John Rosevear joins the podcast to break down the political issues that have sidetracked the merger and discuss why we’ve been seeing so many major automotive partnerships recently, both between OEMs and autonomy startups.
Earlier this month, industry watchers gathered at the annual American Society of Clinical Oncology (ASCO) conference to discuss the latest research in the battle against cancer. In today's show, biotech investing expert Brad Loncar shares his key takeaways from the event, including must-hear insight into programs underway at Iovance Biotherapeutics, MacroGenics, and the biotech unicorn, Grail.
Mortgage REITs can be attractive to income investors, with many sporting double-digit yields, but it’s important to know what you’re getting into before adding one to your portfolio. In this Industry Focus: Financialsepisode, Fool.com contributor Matt Frankel, CFP discusses the basics of this unique type of company. Plus, host Jason Moser gives his take on Docusign’s (NASDAQ: DOCU) latest earnings report, and the pair answer some listener emails. You’ll hear all this and more on this week’s episode!
Since the oil price collapse of 2014, offshore drillers have languished, with several operators going bankrupt. However, stabilizing oil prices and declining breakeven levels for offshore oil has the industry poised for a turnaround. Motley Fool Contributor Jason Hall joins the show to discuss the current state of the industry and break down three major offshore operators.
Get more great information on becoming a better investor -- free and straight to your inbox!
By submitting your email address, you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. You can unsubscribe at any time. Please read our Privacy Statement and Terms & Conditions.